AbbVie (ABBV) Insider Trading & Ownership $202.79 +1.49 (+0.74%) Closing price 03/27/2025 03:59 PM EasternExtended Trading$203.12 +0.34 (+0.17%) As of 03/27/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AbbVie (NYSE:ABBV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.25%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$73.28 M Get ABBV Insider Trade Alerts Want to know when executives and insiders are buying or selling AbbVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABBV Insider Buying and Selling by Quarter Remove Ads AbbVie Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/17/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$214.45$1,001 - $15,0002/26/2025Kevin K BuckbeeSVPSell18,944$203.41$3,853,399.04 2/26/2025Timothy J RichmondEVPSell29,917$202.90$6,070,159.30 2/24/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$204.02$50,001 - $100,0002/20/2025Perry C SiatisEVPSell5,778$197.90$1,143,466.20 1/15/2025Jared MoskowitzU.S. Congress Member (D-FL)Buy$171.32$1,001 - $15,00012/16/2024Kevin K BuckbeeSVPSell1,800$172.24$310,032.00 12/6/2024Virginia FoxxU.S. Congress Member (R-NC)Buy$176.18$1,001 - $15,00011/20/2024Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$167.74$1,001 - $15,0009/4/2024John JamesU.S. Congress Member (R-MI)Sell$197.00$1,001 - $15,0008/5/2024Richard A GonzalezChairmanSell66,500$186.52$12,403,580.00 7/17/2024Richard A GonzalezChairmanSell282,845$175.00$49,497,875.00 (Data available from 1/1/2013 forward) ABBV Insider Trading Activity - Frequently Asked Questions Who is on AbbVie's Insider Roster? The list of insiders at AbbVie includes Azita Saleki-Gerhardt, Carrie C Strom, Elaine K Sorg, Henry O Gosebruch, Jeffrey Ryan Stewart, Kevin K Buckbee, Michael Severino, Nicholas Donoghoe, Perry C Siatis, Richard A Gonzalez, Robert A Michael, Roxanne S Austin, Scott T Reents, and Timothy J Richmond. Learn more on insiders at ABBV. What percentage of AbbVie stock is owned by insiders? 0.25% of AbbVie stock is owned by insiders. Learn more on ABBV's insider holdings. Which AbbVie insiders have been selling company stock? The following insiders have sold ABBV shares in the last 24 months: Azita Saleki-Gerhardt ($9,184,047.70), Elaine K Sorg ($4,624,583.39), Jeffrey Ryan Stewart ($10,539,491.71), Kevin K Buckbee ($5,072,118.64), Nicholas Donoghoe ($4,167,301.24), Perry C Siatis ($5,902,525.72), Richard A Gonzalez ($89,233,188.32), Robert A Michael ($12,153,699.55), Scott T Reents ($2,509,001.60), and Timothy J Richmond ($6,070,159.30). How much insider selling is happening at AbbVie? Insiders have sold a total of 842,671 AbbVie shares in the last 24 months for a total of $149,456,117.17 sold. Which members of congress are trading AbbVie? Marjorie Taylor Greene (R-GA), Jefferson Shreve (R-IN), Jared Moskowitz (D-FL), Virginia Foxx (R-NC), Kathy E. Manning (D-NC), and Tommy Tuberville (R-AL) have bought shares of AbbVie in the last year totaling $123,000. John James (R-MI) and Michael C. Burgess (R-TX) have sold shares totaling $16,000. AbbVie Key ExecutivesMr. Richard A. Gonzalez (Age 70)Chairman & CEO Compensation: $7.19MMr. Robert A. Michael (Age 54)President & COO Compensation: $4.62MMr. Scott T. Reents (Age 56)Executive VP & CFO Compensation: $3.13MDr. Azita Saleki-Gerhardt Ph.D. (Age 61)Executive VP & COO Compensation: $3.51MMr. Jeffrey Ryan Stewart (Age 55)Executive VP & Chief Commercial Officer Compensation: $4.32MDr. Thomas J. Hudson M.D. (Age 62)Senior VP & Chief Scientific Officer of Global Research Ms. Elizabeth SheaSenior Vice President of Investor RelationsMr. Perry C. Siatis (Age 49)Executive VP, General Counsel & Secretary 1 recent tradesMr. Sanjay NarayanSenior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic LegalMr. Timothy J. Richmond (Age 58)Executive VP & Chief Human Resources Officer Compensation: $1.12M1 recent trades More Insider Trading Tools from MarketBeat Related Companies Eli Lilly and Company Insider Ownership Johnson & Johnson Insider Ownership Merck & Co., Inc. Insider Ownership Pfizer Insider Ownership Bristol-Myers Squibb Insider Ownership Zoetis Insider Ownership Royalty Pharma Insider Ownership Jazz Pharmaceuticals Insider Ownership Corcept Therapeutics Insider Ownership Perrigo Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NYSE:ABBV) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
